Psychopathological Risk Factors Associated With Conversion From Mild Cognitive Impairment to Dementia
NCT ID: NCT01436552
Last Updated: 2011-09-19
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
392 participants
OBSERVATIONAL
2010-02-28
2014-02-28
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Purpose: Actually, there is no study concerning the rate of conversion from MCI to dementia according to the presence or not of TLE. The aim of this study is to assess association between TLE and conversion rate from MCI to dementia.
Methods: Patients with MCI will be recruited in different memory clinics (Limoges and others) Primary outcome: Occurrence of dementia according to DSM-IV-TR criteria in MCI patients according to their cumulated score of TLE measured by EVVIE.
Secondary outcomes: Occurrence of dementia in MCI patients according to various other psychopathological factors: anxiety, depression, apathy, personality features, alexithymia and resilience levels and life style.
Study design: Epidemiologic cohort longitudinal and prospective multicenter study.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Predicting the Conversion From Mild Cognitive Impairment to Dementia
NCT01823666
Loneliness as Risk Factor for Dementia
NCT07211945
Dementia and Mild Cognitive Impairment: Assessment of Cognitive Functioning, Functional Autonomy, and Neuropsychiatric Symptoms.
NCT07287410
Depression, Anxiety and Social Relationships as Risk Factors for Dementia
NCT04786561
Predictive Value of Cognitive Tests Performed for the Diagnosis of Alzheimer's Disease and Related Disorders
NCT01316562
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
* Inclusion criteria:
* Man or woman ≥ 50 years.
* Patient with MCI, of any type, according to the criteria of Petersen et al, 2001.
* Clinical Dementia Rating (CDR) ≤ 0,5.
* Instrumental activities of daily living (IADL)=0.
* MMSE \> 26.
* Cognitive and functional capacities well enough in order to avoid a possible diagnosis of Alzheimer's disease based on clinical evidences (DSM-IV TR) cannot be done during initial visit.
* Ambulatory patient.
* Visual and auditory capabilities (equipment allowed) and oral or written capacity able for the development of suitable tests (according to the clinician).
* exclusion criteria:
* Patient with identified neurological problems.
* Patient with developing and/ or non-stabilized psychiatric disease.
* Patient with biological disorders observed during diagnostic process. Number of subjects: 392 subjects Statistical analysis: Statistical analyses will be performed by the Unité Fonctionnelle de Recherche Clinique et de Biostatistique from the Limoges teaching hospital using SAS® V 9.1.3 software (SAS Institute Cary, NC). Level of significance will be 0.05 for all analyses. Statistical analyses will be performed and presented in agreement with STROBE guidelines.
Descriptive analyses
Quantitative variables will be described using mean ± standard deviation or median and interquartile range. Qualitative variables will be described using frequencies, percentages and 95% confidence intervals assessed with exact method.
A flow chart of patients will be presented.
Main analysis Association between dementia and EVVIE score will be assessed through relative risk calculation. 95% confidence interval will also be calculated.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patient with MCI, of any type, according to the criteria of Petersen et al, 2001.
* Clinical Dementia Rating (CDR) ≤ 0,5.
* Instrumental activities of daily living (IADL)=0.
* MMSE \> 26.
* Cognitive and functional capacities well enough in order to avoid a possible diagnosis of Alzheimer's disease based on clinical evidences (DSM-IV TR) cannot be done during initial visit.
* Ambulatory patient.
* Visual and auditory capabilities (equipment allowed) and oral or written capacity able for the development of suitable tests (according to the clinician).
Exclusion Criteria
* Patient with developing and/ or non-stabilized psychiatric disease.
* Patient with biological disorders observed during diagnostic process.
50 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Centre Hospitalier Esquirol
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Jean Pierre Clement
Professor of Psychiatry -Ph.D
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Jean-Pierre Clement, MD, PhD
Role: PRINCIPAL_INVESTIGATOR
CH Esquirol
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
CH Esquirol
Limoges, , France
Countries
Review the countries where the study has at least one active or historical site.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
B1001104-10
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.